Global Influenza Virus Vaccine (H1N1) Market Research Report 2023

Influenza Virus Vaccine (H1N1) Market

Influenza Virus Vaccine (H1N1), which is specifically designed to protect against the a (H1N1) virus, previously known as swine flu.

The global Influenza Virus Vaccine (H1N1) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Influenza Virus Vaccine (H1N1) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Influenza Virus Vaccine (H1N1) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Influenza Virus Vaccine (H1N1) include CSL, NVS(Novartis), Sanofi Pasteur, Medimmune, GSK, Baxter, Beijing Kexing Bio-Vaccine, Hualan Bio-Vaccine and Changchun Changsheng Bio-Technology, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza Virus Vaccine (H1N1), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Virus Vaccine (H1N1).

The Influenza Virus Vaccine (H1N1) market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Influenza Virus Vaccine (H1N1) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Influenza Virus Vaccine (H1N1) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Influenza Virus Vaccine (H1N1) Market Report

Core Chapters

1.1 Product Overview and Scope of Influenza Virus Vaccine (H1N1)

1.2 Influenza Virus Vaccine (H1N1) Segment by Type

1.2.1 Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Type (2023-2029)

1.2.2 Intramuscular Vaccine

1.2.3 Nasal Spray Vaccine

1.3 Influenza Virus Vaccine (H1N1) Segment by Application

1.3.1 Global Influenza Virus Vaccine (H1N1) Market Value by Application: (2023-2029)

1.3.2 3 To 10 Years Old

1.3.3 10 To 18 Years Old

1.3.4 Above 18 Years Old

1.3.5 Other

1.4 Global Influenza Virus Vaccine (H1N1) Market Size Estimates and Forecasts

1.4.1 Global Influenza Virus Vaccine (H1N1) Revenue 2018-2029

1.4.2 Global Influenza Virus Vaccine (H1N1) Sales 2018-2029

1.4.3 Global Influenza Virus Vaccine (H1N1) Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2018-2023)

2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Influenza Virus Vaccine (H1N1) Average Price by Manufacturers (2018-2023)

2.4 Global Influenza Virus Vaccine (H1N1) Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Product Type & Application

2.7 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends

2.7.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Influenza Virus Vaccine (H1N1) Players Market Share by Revenue

2.7.3 Global Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Influenza Virus Vaccine (H1N1) Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Influenza Virus Vaccine (H1N1) Global Influenza Virus Vaccine (H1N1) Sales by Region: 2018-2029

3.2.1 Global Influenza Virus Vaccine (H1N1) Sales by Region: 2018-2023

3.2.2 Global Influenza Virus Vaccine (H1N1) Sales by Region: 2024-2029

3.3 Global Influenza Virus Vaccine (H1N1) Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2018-2029

3.3.1 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2018-2023

3.3.2 Global Influenza Virus Vaccine (H1N1) Revenue by Region: 2024-2029

3.4 North America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country

3.4.1 North America Influenza Virus Vaccine (H1N1) Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Influenza Virus Vaccine (H1N1) Sales by Country (2018-2029)

3.4.3 North America Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country

3.5.1 Europe Influenza Virus Vaccine (H1N1) Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Influenza Virus Vaccine (H1N1) Sales by Country (2018-2029)

3.5.3 Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country

3.6.1 Asia Pacific Influenza Virus Vaccine (H1N1) Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Country (2018-2029)

3.6.3 Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country

3.7.1 Latin America Influenza Virus Vaccine (H1N1) Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2018-2029)

3.7.3 Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Facts & Figures by Country

3.8.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2018-2029)

3.8.3 Middle East and Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2018-2029)

4.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Type (2018-2023)

4.1.2 Global Influenza Virus Vaccine (H1N1) Sales by Type (2024-2029)

4.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2029)

4.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2018-2029)

4.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2018-2023)

4.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Type (2024-2029)

4.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2018-2029)

4.3 Global Influenza Virus Vaccine (H1N1) Price by Type (2018-2029)

5.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2018-2029)

5.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Application (2018-2023)

5.1.2 Global Influenza Virus Vaccine (H1N1) Sales by Application (2024-2029)

5.1.3 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2029)

5.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2018-2029)

5.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2018-2023)

5.2.2 Global Influenza Virus Vaccine (H1N1) Revenue by Application (2024-2029)

5.2.3 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2018-2029)

5.3 Global Influenza Virus Vaccine (H1N1) Price by Application (2018-2029)

6.1 CSL

6.1.1 CSL Corporation Information

6.1.2 CSL Description and Business Overview

6.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.1.4 CSL Influenza Virus Vaccine (H1N1) Product Portfolio

6.1.5 CSL Recent Developments/Updates

6.2 NVS(Novartis)

6.2.1 NVS(Novartis) Corporation Information

6.2.2 NVS(Novartis) Description and Business Overview

6.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.2.4 NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Portfolio

6.2.5 NVS(Novartis) Recent Developments/Updates

6.3 Sanofi Pasteur

6.3.1 Sanofi Pasteur Corporation Information

6.3.2 Sanofi Pasteur Description and Business Overview

6.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Portfolio

6.3.5 Sanofi Pasteur Recent Developments/Updates

6.4 Medimmune

6.4.1 Medimmune Corporation Information

6.4.2 Medimmune Description and Business Overview

6.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Medimmune Influenza Virus Vaccine (H1N1) Product Portfolio

6.4.5 Medimmune Recent Developments/Updates

6.5 GSK

6.5.1 GSK Corporation Information

6.5.2 GSK Description and Business Overview

6.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.5.4 GSK Influenza Virus Vaccine (H1N1) Product Portfolio

6.5.5 GSK Recent Developments/Updates

6.6 Baxter

6.6.1 Baxter Corporation Information

6.6.2 Baxter Description and Business Overview

6.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Baxter Influenza Virus Vaccine (H1N1) Product Portfolio

6.6.5 Baxter Recent Developments/Updates

6.7 Beijing Kexing Bio-Vaccine

6.6.1 Beijing Kexing Bio-Vaccine Corporation Information

6.6.2 Beijing Kexing Bio-Vaccine Description and Business Overview

6.6.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio

6.7.5 Beijing Kexing Bio-Vaccine Recent Developments/Updates

6.8 Hualan Bio-Vaccine

6.8.1 Hualan Bio-Vaccine Corporation Information

6.8.2 Hualan Bio-Vaccine Description and Business Overview

6.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Portfolio

6.8.5 Hualan Bio-Vaccine Recent Developments/Updates

6.9 Changchun Changsheng Bio-Technology

6.9.1 Changchun Changsheng Bio-Technology Corporation Information

6.9.2 Changchun Changsheng Bio-Technology Description and Business Overview

6.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio

6.9.5 Changchun Changsheng Bio-Technology Recent Developments/Updates

6.10 Beijing Tiantan Bio-Products

6.10.1 Beijing Tiantan Bio-Products Corporation Information

6.10.2 Beijing Tiantan Bio-Products Description and Business Overview

6.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Portfolio

6.10.5 Beijing Tiantan Bio-Products Recent Developments/Updates

6.11 Jiangsu Yanshen Bio-Technology

6.11.1 Jiangsu Yanshen Bio-Technology Corporation Information

6.11.2 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Description and Business Overview

6.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Portfolio

6.11.5 Jiangsu Yanshen Bio-Technology Recent Developments/Updates

6.12 Zhejiang Tianyuan Bio-Pharmaceutical

6.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information

6.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description and Business Overview

6.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio

6.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates

6.13 Dalian Yalifeng Bio-Pharmaceutical

6.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information

6.13.2 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Description and Business Overview

6.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Portfolio

6.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates

6.14 Sinopharm

6.14.1 Sinopharm Corporation Information

6.14.2 Sinopharm Influenza Virus Vaccine (H1N1) Description and Business Overview

6.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Product Portfolio

6.14.5 Sinopharm Recent Developments/Updates

7.1 Influenza Virus Vaccine (H1N1) Industry Chain Analysis

7.2 Influenza Virus Vaccine (H1N1) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Influenza Virus Vaccine (H1N1) Production Mode & Process

7.4 Influenza Virus Vaccine (H1N1) Sales and Marketing

7.4.1 Influenza Virus Vaccine (H1N1) Sales Channels

7.4.2 Influenza Virus Vaccine (H1N1) Distributors

7.5 Influenza Virus Vaccine (H1N1) Customers

8.1 Influenza Virus Vaccine (H1N1) Industry Trends

8.2 Influenza Virus Vaccine (H1N1) Market Drivers

8.3 Influenza Virus Vaccine (H1N1) Market Challenges

8.4 Influenza Virus Vaccine (H1N1) Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Influenza Virus Vaccine (H1N1) Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) of Key Manufacturers (2018-2023)

    Table 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Influenza Virus Vaccine (H1N1), Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Product Type & Application

    Table 12. Global Key Manufacturers of Influenza Virus Vaccine (H1N1), Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Influenza Virus Vaccine (H1N1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Influenza Virus Vaccine (H1N1) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Influenza Virus Vaccine (H1N1) Sales by Region (2018-2023) & (K Doses)

    Table 18. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2018-2023)

    Table 19. Global Influenza Virus Vaccine (H1N1) Sales by Region (2024-2029) & (K Doses)

    Table 20. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2024-2029)

    Table 21. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2018-2023)

    Table 23. Global Influenza Virus Vaccine (H1N1) Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2024-2029)

    Table 25. North America Influenza Virus Vaccine (H1N1) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)

    Table 27. North America Influenza Virus Vaccine (H1N1) Sales by Country (2024-2029) & (K Doses)

    Table 28. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Influenza Virus Vaccine (H1N1) Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Influenza Virus Vaccine (H1N1) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)

    Table 32. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2024-2029) & (K Doses)

    Table 33. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Influenza Virus Vaccine (H1N1) Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2018-2023) & (K Doses)

    Table 37. Asia Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2024-2029) & (K Doses)

    Table 38. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)

    Table 42. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2024-2029) & (K Doses)

    Table 43. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Influenza Virus Vaccine (H1N1) Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2018-2023) & (K Doses)

    Table 47. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales by Country (2024-2029) & (K Doses)

    Table 48. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2018-2023)

    Table 51. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2024-2029)

    Table 52. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2018-2023)

    Table 53. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Type (2024-2029)

    Table 54. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2018-2023)

    Table 57. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Type (2024-2029)

    Table 58. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2018-2023)

    Table 59. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2024-2029)

    Table 60. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2018-2023)

    Table 61. Global Influenza Virus Vaccine (H1N1) Sales (K Doses) by Application (2024-2029)

    Table 62. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2018-2023)

    Table 63. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Application (2024-2029)

    Table 64. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Influenza Virus Vaccine (H1N1) Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2018-2023)

    Table 67. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Application (2024-2029)

    Table 68. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2018-2023)

    Table 69. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2024-2029)

    Table 70. CSL Corporation Information

    Table 71. CSL Description and Business Overview

    Table 72. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 73. CSL Influenza Virus Vaccine (H1N1) Product

    Table 74. CSL Recent Developments/Updates

    Table 75. NVS(Novartis) Corporation Information

    Table 76. NVS(Novartis) Description and Business Overview

    Table 77. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 78. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product

    Table 79. NVS(Novartis) Recent Developments/Updates

    Table 80. Sanofi Pasteur Corporation Information

    Table 81. Sanofi Pasteur Description and Business Overview

    Table 82. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 83. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product

    Table 84. Sanofi Pasteur Recent Developments/Updates

    Table 85. Medimmune Corporation Information

    Table 86. Medimmune Description and Business Overview

    Table 87. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 88. Medimmune Influenza Virus Vaccine (H1N1) Product

    Table 89. Medimmune Recent Developments/Updates

    Table 90. GSK Corporation Information

    Table 91. GSK Description and Business Overview

    Table 92. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 93. GSK Influenza Virus Vaccine (H1N1) Product

    Table 94. GSK Recent Developments/Updates

    Table 95. Baxter Corporation Information

    Table 96. Baxter Description and Business Overview

    Table 97. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 98. Baxter Influenza Virus Vaccine (H1N1) Product

    Table 99. Baxter Recent Developments/Updates

    Table 100. Beijing Kexing Bio-Vaccine Corporation Information

    Table 101. Beijing Kexing Bio-Vaccine Description and Business Overview

    Table 102. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 103. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product

    Table 104. Beijing Kexing Bio-Vaccine Recent Developments/Updates

    Table 105. Hualan Bio-Vaccine Corporation Information

    Table 106. Hualan Bio-Vaccine Description and Business Overview

    Table 107. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 108. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product

    Table 109. Hualan Bio-Vaccine Recent Developments/Updates

    Table 110. Changchun Changsheng Bio-Technology Corporation Information

    Table 111. Changchun Changsheng Bio-Technology Description and Business Overview

    Table 112. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 113. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product

    Table 114. Changchun Changsheng Bio-Technology Recent Developments/Updates

    Table 115. Beijing Tiantan Bio-Products Corporation Information

    Table 116. Beijing Tiantan Bio-Products Description and Business Overview

    Table 117. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 118. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product

    Table 119. Beijing Tiantan Bio-Products Recent Developments/Updates

    Table 120. Jiangsu Yanshen Bio-Technology Corporation Information

    Table 121. Jiangsu Yanshen Bio-Technology Description and Business Overview

    Table 122. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 123. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product

    Table 124. Jiangsu Yanshen Bio-Technology Recent Developments/Updates

    Table 125. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information

    Table 126. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview

    Table 127. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 128. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product

    Table 129. Zhejiang Tianyuan Bio-Pharmaceutical Recent Developments/Updates

    Table 130. Dalian Yalifeng Bio-Pharmaceutical Corporation Information

    Table 131. Dalian Yalifeng Bio-Pharmaceutical Description and Business Overview

    Table 132. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 133. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product

    Table 134. Dalian Yalifeng Bio-Pharmaceutical Recent Developments/Updates

    Table 135. Sinopharm Corporation Information

    Table 136. Sinopharm Description and Business Overview

    Table 137. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)

    Table 138. Sinopharm Influenza Virus Vaccine (H1N1) Product

    Table 139. Sinopharm Recent Developments/Updates

    Table 140. Key Raw Materials Lists

    Table 141. Raw Materials Key Suppliers Lists

    Table 142. Influenza Virus Vaccine (H1N1) Distributors List

    Table 143. Influenza Virus Vaccine (H1N1) Customers List

    Table 144. Influenza Virus Vaccine (H1N1) Market Trends

    Table 145. Influenza Virus Vaccine (H1N1) Market Drivers

    Table 146. Influenza Virus Vaccine (H1N1) Market Challenges

    Table 147. Influenza Virus Vaccine (H1N1) Market Restraints

    Table 148. Research Programs/Design for This Report

    Table 149. Key Data Information from Secondary Sources

    Table 150. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Influenza Virus Vaccine (H1N1)

    Figure 2. Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Influenza Virus Vaccine (H1N1) Market Share by Type in 2022 & 2029

    Figure 4. Intramuscular Vaccine Product Picture

    Figure 5. Nasal Spray Vaccine Product Picture

    Figure 6. Global Influenza Virus Vaccine (H1N1) Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Influenza Virus Vaccine (H1N1) Market Share by Application in 2022 & 2029

    Figure 8. 3 To 10 Years Old

    Figure 9. 10 To 18 Years Old

    Figure 10. Above 18 Years Old

    Figure 11. Other

    Figure 12. Global Influenza Virus Vaccine (H1N1) Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Influenza Virus Vaccine (H1N1) Market Size (2018-2029) & (US$ Million)

    Figure 14. Global Influenza Virus Vaccine (H1N1) Sales (2018-2029) & (K Doses)

    Figure 15. Global Influenza Virus Vaccine (H1N1) Average Price (US$/Dose) & (2018-2029)

    Figure 16. Influenza Virus Vaccine (H1N1) Report Years Considered

    Figure 17. Influenza Virus Vaccine (H1N1) Sales Share by Manufacturers in 2022

    Figure 18. Global Influenza Virus Vaccine (H1N1) Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest Influenza Virus Vaccine (H1N1) Players: Market Share by Revenue in 2022

    Figure 20. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global Influenza Virus Vaccine (H1N1) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2029)

    Figure 23. North America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2029)

    Figure 27. Europe Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2029)

    Figure 28. Germany Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific Influenza Virus Vaccine (H1N1) Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific Influenza Virus Vaccine (H1N1) Revenue Market Share by Region (2018-2029)

    Figure 35. China Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Influenza Virus Vaccine (H1N1) Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Influenza Virus Vaccine (H1N1) Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Influenza Virus Vaccine (H1N1) Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Influenza Virus Vaccine (H1N1) by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Influenza Virus Vaccine (H1N1) by Type (2018-2029)

    Figure 57. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Influenza Virus Vaccine (H1N1) by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Influenza Virus Vaccine (H1N1) by Application (2018-2029)

    Figure 60. Global Influenza Virus Vaccine (H1N1) Price (US$/Dose) by Application (2018-2029)

    Figure 61. Influenza Virus Vaccine (H1N1) Value Chain

    Figure 62. Influenza Virus Vaccine (H1N1) Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed